Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review

Overview

Journal Cell Biochem Biophys

Specialties Biochemistry
Biophysics
Cell Biology

Date 2024 Sep 3

PMID 39225902

Authors

Shireen Hamid Farhan

Saade Abdalkareem Jasim

Pooja Bansal

Harpreet Kaur

Mohammed Abed Jawad

Maytham T Qasim

Abeer Mhussan Jabbar

Mahamedha Deorari

Ahmed Alawadi

Ali Hadi

Affiliations

Soon will be listed here.

Abstract

Inflammation and autoimmune diseases (AD) are common outcomes of an overactive immune system. Inflammation occurs due to the immune system reacting to damaging stimuli. Exosomes are being recognized as an advanced therapeutic approach for addressing an overactive immune system, positioning them as a promising option for treating AD. Mesenchymal stem cells (MSCs) release exosomes that have strong immunomodulatory effects, influenced by their cell of origin. MSCs-exosomes, being a cell-free therapy, exhibit less toxicity and provoke a diminished immune response compared to cell-based therapies. Exosomal non-coding RNAs (ncRNA), particularly microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are intricately linked to various biological and functional aspects of human health. Exosomal ncRNAs can lead to tissue malfunction, aging, and illnesses when they experience tissue-specific alterations as a result of various internal or external problems. In this study, we will examine current trends in exosomal ncRNA researches regarding AD. Then, therapeutic uses of MSCs-exosomal ncRNA will be outlined, with a particle focus on the underlying molecular mechanisms.

Citing Articles

Anti-Tumor Effects of Sheep Umbilical Cord Mesenchymal Stem Cells on Melanoma Cells.

Yue F, Zhao Y, Lv Y, Li S, Wang W, Li Y Int J Mol Sci. 2025; 26(1.

PMID: 39796281 PMC: 11720557. DOI: 10.3390/ijms26010426.

References

Batrakova E, Kim M . Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015; 219:396-405. PMC: 4656109. DOI: 10.1016/j.jconrel.2015.07.030. View

Harrell C, Volarevic V, Djonov V, Volarevic A . Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases. Int J Mol Sci. 2022; 23(9). PMC: 9105552. DOI: 10.3390/ijms23094487. View

Tavakoli S, Ghaderi Jafarbeigloo H, Shariati A, Jahangiryan A, Jadidi F, Jadidi Kouhbanani M . Mesenchymal stromal cells; a new horizon in regenerative medicine. J Cell Physiol. 2020; 235(12):9185-9210. DOI: 10.1002/jcp.29803. View

Yan H, Bu P . Non-coding RNA in cancer. Essays Biochem. 2021; 65(4):625-639. PMC: 8564738. DOI: 10.1042/EBC20200032. View

Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y . Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Mol Ther. 2022; 30(10):3133-3154. PMC: 9552915. DOI: 10.1016/j.ymthe.2022.01.046. View

Saw P, Xu X, Chen J, Song E . Non-coding RNAs: the new central dogma of cancer biology. Sci China Life Sci. 2020; 64(1):22-50. DOI: 10.1007/s11427-020-1700-9. View

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

de Almeida R, Fraczek M, Parker S, Delneri D, OKeefe R . Non-coding RNAs and disease: the classical ncRNAs make a comeback. Biochem Soc Trans. 2016; 44(4):1073-8. PMC: 6042638. DOI: 10.1042/BST20160089. View

Das T, Das T, Khodarkovskaya A, Dash S . Non-coding RNAs and their bioengineering applications for neurological diseases. Bioengineered. 2021; 12(2):11675-11698. PMC: 8810045. DOI: 10.1080/21655979.2021.2003667. View

11.

Yoon D, Kim E, Cho S, Jung S, Lee K, Park K . RUNX2 stabilization by long non-coding RNAs contributes to hypertrophic changes in human chondrocytes. Int J Biol Sci. 2023; 19(1):13-33. PMC: 9760429. DOI: 10.7150/ijbs.74895. View

12.

Walravens A, Smolgovsky S, Li L, Kelly L, Antes T, Peck K . Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA. Sci Rep. 2021; 11(1):8666. PMC: 8060398. DOI: 10.1038/s41598-021-87939-9. View

13.

Nawaz M . Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance. Stem Cell Investig. 2017; 4:83. PMC: 5676198. DOI: 10.21037/sci.2017.10.04. View

14.

Jin Y, Xu M, Zhu H, Dong C, Ji J, Liu Y . Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. J Cell Mol Med. 2021; 25(19):9281-9294. PMC: 8500984. DOI: 10.1111/jcmm.16860. View

15.

Fatima F, Ekstrom K, Nazarenko I, Maugeri M, Valadi H, Hill A . Non-coding RNAs in Mesenchymal Stem Cell-Derived Extracellular Vesicles: Deciphering Regulatory Roles in Stem Cell Potency, Inflammatory Resolve, and Tissue Regeneration. Front Genet. 2017; 8:161. PMC: 5662888. DOI: 10.3389/fgene.2017.00161. View

16.

Fang J, Zhang Y, Chen D, Zheng Y, Jiang J . Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction. Int J Nanomedicine. 2022; 17:4699-4719. PMC: 9547598. DOI: 10.2147/IJN.S377479. View

17.

Chen Y, Wu Y, Guo L, Yuan S, Sun J, Zhao K . Exosomal Lnc NEAT1 from endothelial cells promote bone regeneration by regulating macrophage polarization via DDX3X/NLRP3 axis. J Nanobiotechnology. 2023; 21(1):98. PMC: 10029245. DOI: 10.1186/s12951-023-01855-w. View

18.

Huang P, Wang L, Li Q, Tian X, Xu J, Xu J . Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2019; 116(2):353-367. PMC: 8204482. DOI: 10.1093/cvr/cvz139. View

19.

Hou L, Zhu Z, Jiang F, Zhao J, Jia Q, Jiang Q . Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A/miR-223-3p/NLRP3 axis. Ecotoxicol Environ Saf. 2023; 251:114537. DOI: 10.1016/j.ecoenv.2023.114537. View

20.

Wang J, Yan S, Yang J, Lu H, Xu D, Wang Z . Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside. Front Immunol. 2020; 10:3129. PMC: 6997467. DOI: 10.3389/fimmu.2019.03129. View

21.

Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N . Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013; 4:2980. PMC: 3905700. DOI: 10.1038/ncomms3980. View